Replies to post #140438 on Biotech Values

[biomaven0]

I have great hope that this will have big ramifications for NGNM because ABT owns 10% of us and this is what we all were looking for when the deal was signed!

Seems a bit of a stretch to me. ABT has plenty of significant tests (like the FISH test for ALK) that it has not licensed to NGNM. The one we do know about to date has been a dud as best I can tell.

I'm long NGNM but I'm just trying to be realistic here.

Peter